Stereotaxis and Biosense Webster Announce New Strategic Collaboration (STXS)

Stereotaxis, Inc. STXS announced today that it has entered into a new strategic collaboration with Biosense Webster, Inc. related to Stereotaxis' rapidly growing Odyssey™ Solutions. This agreement marks the broadest and most committed cooperative agreement around Odyssey to date. Under the new agreement, Stereotaxis has granted Biosense Webster global, non-exclusive rights to resell Stereotaxis' Odyssey products, including the market leading Odyssey Vision and Odyssey Cinema™ products for electrophysiology (EP) information management.  Odyssey Vision provides unprecedented control of the entire interventional lab as one system with a consolidated view of patient information in a single display.  Odyssey Cinema delivers real-time, remote viewing of live and recorded cases from a laptop anywhere in the world.  Cinema supports the delivery of lab information over an Odyssey Network to revolutionize the way remote proctoring and education is delivered on a global basis.  Stereotaxis' Odyssey business has grown rapidly in recent years, and now supports mission-critical interventional procedures with more than 170 systems sold worldwide in 24 countries.